@article{ajidm20251331,
author={{Ngom, Nd¨¦ye Fatou and Ba, Awa and Diallo, Khardiata and Nadif, Lamyae and Fall, Maguette and Ndiaye, Alassane and Faye, Fulgence Abdou and Ka, Daye and Ka, Oousseynou and Seydi, Moussa},
title={Venous Thromboembolic Complications in Patients with Coronavirus Diseases 2019 Infection Hospitalized in the Infectious and Tropical Diseases Department of CHNU de FANN in Dakar},
journal={American Journal of Infectious Diseases and Microbiology},
volume={13},
number={3},
pages={44--50},
year={2025},
url={https://pubs.sciepub.com/ajidm/13/3/1},
issn={2328-4064},
abstract={<b>Introduction</b>: Coronavirus Disease 2019 (COVID-19) is caused by SARS-CoV-2. High rates of venous thromboembolic disease (VTE) are reported in COVID-19, correlating with severe disease and unexplained deaths. This study aimed to characterize VTE development and associated factors in COVID-19 patients hospitalized at SMIT from January to December 2021. <b>Materials</b><b> </b><b>and</b><b> </b><b>methods</b>: We conducted a retrospective, descriptive, and analytical study of COVID-19 patients with VTE hospitalized at the SMIT, CHNU Fann, Dakar, from January to December 2021. <b>Results</b>: Among 248 hospitalized COVID-19 patients over 12 months, 12 developed VTE, a frequency of 4.84%. Patients were predominantly male (66.67%, sex ratio 1.25) with a mean age of 50.57 years (28-74). Common comorbidities included hypertension, diabetes (both 33.33%), and smoking (25%). RT-PCR was positive in 7 patients, and all 4 patients tested for D-dimer had elevated levels. All patients received corticosteroids and anticoagulation. Antiasthenic were administered in 11 patients, and antibiotics in 10. Only two patients had received a dose of COVID-19 vaccine. The average hospital stay was 10.82 days, with extremes of 1 and 25 days. Smoking was the only significant factor associated with thromboembolic complications. The case fatality rate was 33.33%. <b>Conclusion</b>: Venous thromboembolic complications are common in COVID-19, emphasizing the critical role of COVID-19 prevention. frequent in COVID-19 disease, hence the importance of prevention against COVID-19.},
doi={10.12691/ajidm-13-3-1}
publisher={Science and Education Publishing}
}